SMS Pharmaceuticals Balance Sheet Annual

Trade

BSE: 532815 | NSE: SMSPHARMA | ISIN: INE812G01025 | Sector: Biotechnology & Drugs

248.25 +7.00 (2.90%)Updated : 25 Nov 2024

Interim Data

Annual Data

Fiscal Period	2024	2023	2022	2021
Period End Date	Mar 24	Mar 23	Mar 22	Mar 21
Cash Equivalents	36.04	-	-	-
Short Term Investments	3.28	0.07	12.00	-
Cashand Short Term Investments	39.32	7.38	46.58	40.42
Accounts Receivable- Trade Net	236.23	148.72	48.53	105.79
Total Receivables Net	237.96	171.49	71.65	126.24
Total Inventory	233.70	226.75	255.44	140.36
Other Current Assets Total	22.92	0.09	0.08	0.09
Total Current Assets	533.89	410.65	377.05	309.33
Property/ Plant/ Equipment Total- Net	464.87	443.74	447.63	462.50
Intangibles Net	2.66	1.47	1.37	1.60
Long Term Investments	16.11	10.52	21.53	27.30
Other Long Term Assets Total	16.56	7.62	7.63	5.84
Total Assets	1,034.09	879.61	859.50	812.21
Accounts Payable	151.32	113.15	72.86	65.44
Current Portof LT Debt/ Capital Leases	158.68	38.53	43.74	31.82
Other Currentliabilities Total	21.71	9.22	11.71	25.79
Total Current Liabilities	331.72	254.91	196.48	194.09
Long Term Debt	122.09	121.13	149.50	147.84
Capital Lease Obligations	0.00	0.61	2.11	4.06
Total Long Term Debt	122.09	121.75	151.62	151.90
Total Debt	280.77	254.07	263.27	254.58
Deferred Income Tax	42.80	41.02	39.55	53.85
Other Liabilities Total	1.16	1.40	1.57	1.84
Total Liabilities	497.76	419.08	389.21	401.68
Common Stock Total	8.47	8.47	8.47	8.47
Retained Earnings( Accumulated Deficit)	527.86	382.24	392.01	332.24
Total Equity	536.33	460.53	470.29	410.53
Total Liabilities Shareholders' Equity	1,034.09	879.61	859.50	812.21
Total Common Shares Outstanding	8.47	8.47	8.47	8.47
Tangible Book Valueper Share Common Eq	63.04	54.23	55.39	48.31
Cash	-	7.31	34.58	40.42
Prepaid Expenses	-	4.93	3.31	2.22
Property/ Plant/ Equipment Total- Gross	-	605.41	578.19	562.63
Accumulated Depreciation Total	-	-161.67	-130.57	-100.12
Note Receivable- Long Term	-	5.61	4.30	5.63
Accrued Expenses	-	0.22	0.26	0.18
Notes Payable/ Short Term Debt	-	93.79	67.91	70.86
Additional Paid- In Capital	-	69.82	69.82	69.82